Methods Executive

Following recent structure and function reviews in Cochrane, we remodelled the Methods Executive to provide a leadership forum that ensures all key methodological roles e.g. Editorial Board, Scientific Committee, Council representatives and the Senior Methods Advisor to the Editor in Chief are able to meet and liaise. The Executive also has a primary function to oversee Methods Groups, particularly lead convenors.
  • Holger Sch√ľnemann (GRADEing) continues as co-Chair of the Executive and is joined by Carl Moons (Prognosis).¬† We would like to thank Jane Noyes (Qualitative and Implementation) a co-chair of the Executive for many years for her support as she steps down.
  • Two new convenor members, Carl Moons (Prognosis) and Su Golder (Adverse Effects) joined the Executive at the September 2018 meeting at the Edinburgh Colloquium, along with Julian Higgins (Senior Methods Advisor, Handbook editor), Miranda Langendam and Yemisi Takwoingi (Council representatives).
  • Jane Noyes, Jo McKenzie, and Carol Lefebvre continue to be Executive members.
  • We would like to thank the following members who stepped down in 2018: Ian Shemilt (Economics), Isabelle Boutron (Bias), Sally Hopewell (Methodology Reviews) and Mariska Leeflang (Diagnositic Test Accuracy) for their support to Cochrane.
Further information on the new Methods Executive please download PDF. This document remains in draft and is undergoing further review.